Clinical Evaluation of Two Daily Disposable Contact Lenses

NCT ID: NCT01163760

Last Updated: 2018-06-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to evaluate the clinical performance of two daily disposable contact lenses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Error

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

etafilcon A / ocufilcon D

etafilcon A contact lens worn first daily disposable , ocufilcon D contact lens worn second daily disposable

Group Type OTHER

etafilcon A

Intervention Type DEVICE

daily disposable contact lens

ocufilcon D

Intervention Type DEVICE

daily disposable contact lens

oculfilcon D / etafilcon A

ocufilcon D contact lens worn first, etafilcon A contact lens worn second

Group Type OTHER

etafilcon A

Intervention Type DEVICE

daily disposable contact lens

ocufilcon D

Intervention Type DEVICE

daily disposable contact lens

ocufilcon D / ocufilcon D

ocufilcon D contact lens worn first and second

Group Type OTHER

ocufilcon D

Intervention Type DEVICE

daily disposable contact lens

etafilcon A / etafilcon A

etafilcon A contact lens worn first and second

Group Type OTHER

etafilcon A

Intervention Type DEVICE

daily disposable contact lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

etafilcon A

daily disposable contact lens

Intervention Type DEVICE

ocufilcon D

daily disposable contact lens

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be between 21 and 39 years of age.
* Signed Written Informed Consent and Investigator to record this on Case Report Form (CRF) in appropriate space.
* Be existing (i.e. successfully worn for 1-month prior to the study) soft contact lens wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed).
* Require a visual correction in both eyes (monovision allowed but no monofit).
* Have a contact lens spherical distance requirement between -1.00D and -6.00D in both eyes.
* Astigmatism of 1.00D or less in both eyes.
* Be able to wear the lens powers available for this study.
* Be correctable to a visual acuity of 20/30 or better in each eye.
* Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:

* No amblyopia.
* No evidence of lid abnormality or infection.
* No conjunctival abnormality or infection.
* No clinically significant slit lamp findings (i.e. edema, staining, scarring, vascularisation, infiltrates or abnormal opacities).
* No other active ocular disease.

Exclusion Criteria

* Requires concurrent ocular medication.
* Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
* Clinically significant (Grade 3 or 4) corneal edema, corneal vascularisation, corneal staining, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear.
* Diabetic.
* Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
* Extended lens wear in last 3 months.
* PMMA or RGP lens wear in the previous 8 weeks.
* Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
* Abnormal lacrimal secretions.
* Pre-existing ocular irritation that would preclude contact lens fitting.
* Keratoconus or other corneal irregularity.
* Pregnancy, lactating or planning a pregnancy at the time of enrollment.
* Participation in any concurrent clinical trial or in last 60 days."
Minimum Eligible Age

21 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Singapore Polytechnic University

UNKNOWN

Sponsor Role collaborator

Visioncare Research Ltd.

OTHER

Sponsor Role collaborator

Johnson & Johnson Vision Care, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRO-518

Identifier Type: -

Identifier Source: secondary_id

CR-0706

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Comparison of Two Contact Lenses
NCT00700752 COMPLETED NA